Isocount is an independent service organisation established in 2003. We are committed to providing service excellence to our customers throughout the UK. Our highly motivated engineers are factory trained, 5 of them being former manufacturer specialists in their respective fields, the engineers previously worked for Packard Bioscience, Wallac and PerkinElmer. Our disciplines and services include: Microplate Readers, Scintillation Counters, Gamma Counters, IR/FT-IR/UV Spectrophotometers, Automated liquid handling, Calibration, Service, Repair, Maintenance, Validation, OQ, Refurbished instrumentation We have been offering quality service to the industry for many years now and have a distinguished customer list, we have also alternatively sourced many parts enabling us to offer replacements for many instruments at very competitive prices.
Isogenica partners with leading pharmaceutical and biotechnology companies in the early-stage discovery of novel biopharmaceuticals. . . Isogenica’s partners can access a range of innovative, highly-diverse, antibody libraries as an excellent starting point for new biotherapeutic development programmes.. . All the company’s libraries are fully synthetic, designed using state-of-the-art principles and built using the company’s highly precise Colibra oligonucletotide contruction technology. The combination of advanced design and accurate synthetic build technology minimises immunological biases, inevitable when using in vivo systems, and optimises the chances of generating high-affinity and developable drug candidates at the outset.. . The company’s proprietary antibody libraries are complemented with the option to use a proprietary in vitro antibody display system (CIS Display) which maintains the high diversity of the library through the discovery process. CIS Display is also available for licensing as a standalone technology.. . Isogenica currently has a range of camelid single domain antibody (VHH) libraries, and a range of human antibody fragment libraries. The company continues to innovate in the design and construction of new, advanced antibody libraries.
No data available
We are one of the largest UK and European Patent and Trade Mark Attorney firms, with offices in London, Oxford, Cambridge, Paris and Munich. The breadth and depth of our technical knowledge relevant to patents is outstanding, with over 70 science and technology graduates in the firm including over 35 PhDs. No area of science or technology is outside our scope. Our trade marks team comprises senior professionals with backgrounds in major international law firms. The team has the expertise and resources to handle any trade marks matter. . . . We draft, file and prosecute patent and trade mark applications in the UK, Europe and the rest of the world. We handle patent oppositions and appeals within Europe, especially before the European Patent Office (EPO), and we can act to protect your patents throughout the world. We assist with cases before the UK Patents Courts and provide expert support for high-profile patent litigation in the UK and elsewhere. We advise on trade mark selection and strategy and we file, defend and oppose trade mark applications in the UK, Europe and the rest of the world. We can obtain global protection for your trade marks through international applications before the World Intellectual Property Organization (WIPO) and by instructing filing and prosecution programmes worldwide. We handle all aspects of design protection in the UK, Europe and the rest of the world.
JensonR+ is a technical consultancy with a mission to promote better health by simplifying the journey from innovation to the marketplace.
Our specialist team is experienced in regulatory affairs, quality assurance and pharmacovigilance.
We know the commercial world and that speed to market and control of expenditure are critical to success.
We know that your business is unique.
We will create the optimal strategy and tailor all parameters to meet the individual and specific needs of your project.
We will work closely with you and listen to your concerns. Through a common understanding, we will help you accomplish your goals.
Our specialist team is experienced in regulatory affairs, quality assurance and pharmacovigilance.
We know the commercial world and that speed to market and control of expenditure are critical to success.
We know that your business is unique.
We will create the optimal strategy and tailor all parameters to meet the individual and specific needs of your project.
We will work closely with you and listen to your concerns. Through a common understanding, we will help you accomplish your goals.
No data available
Fiona is a freelance business advisor looking to connect with peers in the biotech and meditech fields in the UK and the rest of the world.
She has over 25 years of senior management experience in R&D, business development and investment in the biopharmaceutical industry in China. Her previous professional experience includes CBO at Kangpu Biotech and at CD Biopharma, Partner at Hongfeng Ventures, R&D Director at the Chinese Academy of Sciences, Director at HUYA Bioscience, Co-founder of Crimson Biopharma and Partner at Laurel Hollow Capital. Fiona has a PhD in Medical Genetics from Tokyo Women's Medical University, Post-Doc from University of Glasgow, UK, and an MD from Dongnan University School of Medicine.
Please come and let's talk if you have a plan to start innovative drug or health product development or are looking for fundraising and partnership for your projects. I can help you to connect with the right resources for the best results...
She has over 25 years of senior management experience in R&D, business development and investment in the biopharmaceutical industry in China. Her previous professional experience includes CBO at Kangpu Biotech and at CD Biopharma, Partner at Hongfeng Ventures, R&D Director at the Chinese Academy of Sciences, Director at HUYA Bioscience, Co-founder of Crimson Biopharma and Partner at Laurel Hollow Capital. Fiona has a PhD in Medical Genetics from Tokyo Women's Medical University, Post-Doc from University of Glasgow, UK, and an MD from Dongnan University School of Medicine.
Please come and let's talk if you have a plan to start innovative drug or health product development or are looking for fundraising and partnership for your projects. I can help you to connect with the right resources for the best results...
As a partner in science, we focus on bringing people together to overcome global challenges.
Across Europe, we have built a network of leading researchers, entrepreneurs, partners and innovators, active in Life Sciences & Health, Agri & Food, Energy & Chemistry, and High Tech Systems & Materials. All determined to find solutions to the global challenges we face today. All determined to make a difference.
Therefore, we invest, develop and operate specialised assets to complement science clusters across Europe. These are not just standard workspaces. We create environments in which scientific organisations can thrive. Bespoke research facilities that are curated to suit your needs and support future growth.
Within each building and wider science cluster you will find organisations of all sizes, which can help you scale or support you as you need. Whether you need access to talent, research, or capital, you will find connections with the right people, in the right organisation.
With spaces available across the UK including London, Cambridge, Oxfordshire, Manchester and Glasgow, please visit our website to find out more!
Across Europe, we have built a network of leading researchers, entrepreneurs, partners and innovators, active in Life Sciences & Health, Agri & Food, Energy & Chemistry, and High Tech Systems & Materials. All determined to find solutions to the global challenges we face today. All determined to make a difference.
Therefore, we invest, develop and operate specialised assets to complement science clusters across Europe. These are not just standard workspaces. We create environments in which scientific organisations can thrive. Bespoke research facilities that are curated to suit your needs and support future growth.
Within each building and wider science cluster you will find organisations of all sizes, which can help you scale or support you as you need. Whether you need access to talent, research, or capital, you will find connections with the right people, in the right organisation.
With spaces available across the UK including London, Cambridge, Oxfordshire, Manchester and Glasgow, please visit our website to find out more!
All Partners have extensive experience, including senior executive positions in large pharmaceutical and entrepreneurial biotechnology companies. Their collective experience extends across business development and licensing, drug discovery and development, marketing, intellectual property management, venture capital and investment banking.. . Our client list ranges from small European start-ups through established US biotechs to large Japanese pharmaceutical companies. Kagulex Consulting provides a range of business and product development services including:. . -Global Product and Patent Licensing and Corporate Partnering. -Intellectual Property Strategy and Management. -Merger and Acquisition Advice and Due Diligence. -Pre-clinical Planning and Implementation. -Clinical and Regulatory Strategy Development and Implementation. -Strategic Business Plan Development. -Product and Technology Assessment. -Venture Facilitation
As the leading kidney research charity in the UK, nothing is going to stop us in our urgent mission to end kidney disease. We’re here to be heard, to make a difference, to change the future. This is a disease that ruins and destroys lives. It must be stopped.
Over the past 60 years, our research has made an impact. But kidney failure is rising, as are the factors contributing to it, such as diabetes and obesity.
Today, we are more essential than ever.
Kidney disease affects three million people in the UK, treatments can be gruelling and currently there is no cure. Only research will end this and nobody can do it but us, by offering kidney patients and their families hope for the future. We’re taking it on. But we can’t do it without you.
Over the past 60 years, our research has made an impact. But kidney failure is rising, as are the factors contributing to it, such as diabetes and obesity.
Today, we are more essential than ever.
Kidney disease affects three million people in the UK, treatments can be gruelling and currently there is no cure. Only research will end this and nobody can do it but us, by offering kidney patients and their families hope for the future. We’re taking it on. But we can’t do it without you.